Menu
Search
|

Menu

Close
X

DaShenLin Pharmaceutical Group Co Ltd 603233.SS (Shanghai Stock Exchange)

44.48 CNY
+1.22 (+2.82%)
As of Sep 21
chart
Previous Close 43.26
Open 43.88
Volume 1,042,839
3m Avg Volume 1,166,255
Today’s High 45.02
Today’s Low 43.03
52 Week High 77.85
52 Week Low 38.44
Shares Outstanding (mil) 400.01
Market Capitalization (mil) 17,304.43
Forward P/E 33.57
Dividend (Yield %) 0.60 ( 1.39 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.50 Mean rating from 6 analysts

KEY STATS

Revenue (mm, CNY)
FY18
4,083
FY17
7,421
FY16
6,274
EPS (CNY)
FY18
0.720
FY17
1.259
FY16
1.185
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
33.57
39.45
Price to Sales (TTM)
vs sector
2.16
6.13
Price to Book (MRQ)
vs sector
6.17
34.06
Price to Cash Flow (TTM)
vs sector
--
34.37
Total Debt to Equity (MRQ)
vs sector
56.94
51.14
LT Debt to Equity (MRQ)
vs sector
0.00
5.51
Return on Investment (TTM)
vs sector
23.09
60.93
Return on Equity (TTM)
vs sector
23.51
73.70

EXECUTIVE LEADERSHIP

Guangzhi Peng
Chief Financial Officer, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Consumer Non-Cyclicals
Industry: Drug Retailers
Address:

No. 410
410-1, Longxi Avenue, Liwan Dist
GUANGZHOU   GNG   510000

Phone: +8620.81689688

DaShenLin Pharmaceutical Group Co., Ltd. is a China-based company principally engaged in the pharmaceutical retailing business. The Company's primary business includes direct sales and retailing of Chinese and Western medicine, ginseng nourishing herbs and Chinese medicine pieces, health products, medical apparatus and instruments and other commodities. The Company mainly conducts its business within domestic market.

SPONSORED STORIES